Antibodies and Cell Lines for HSV-2 and Influenza Research
Corresponding Organization : Emory University
Other organizations : University of Washington, Fred Hutch Cancer Center, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Ragon Institute of MGH, MIT and Harvard
Variable analysis
- Antibodies listed in Supplemental Table 1
- Cell lines: HaCaT keratinocytes and THP-1
- Recombinant HSV-2 strain 333 encoding the β-gal gene under CMV promoter control
- Stem of influenza hemagglutinin (Flu-HA) strain H1 1999 NC expressed using the vector VRC-3925 in 293F cells
- HSV-2 proteins: gB2, gC2, gH2/gL2, UL19ud, UL25, and gD2
- Not explicitly mentioned
- Not explicitly mentioned
- Positive control: None specified
- Negative control: None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!